表紙
市場調查報告書
商品編碼
1036389

體外循環配件的全球市場:行業趨勢和市場預測(~2028)

Global Cardiopulmonary Bypass Accessory Equipment Market - Industry Trends and Forecast to 2028

出版日期: | 出版商: Data Bridge Market Research Private Limited | 英文 604 Pages | 商品交期: 3-5個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,體外循環配件的全球市場預計將以 5.8% 的複合年增長率增長。

本報告調查了體外循環配件的全球市場,定義和概述了市場,分析了新型冠狀病毒感染(COVID-19)和其他市場影響因素,以及市場規模的變化。它按各種類別總結了預測、細分如產品/運營/用途/年齡/最終用戶/地區/主要國家、競爭環境、主要公司簡介等。

目錄

第 1 章介紹

第二章市場分類

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章全球心肺旁路配件市場:區域概覽

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第六章法律法規

第 7 章市場概覽

  • 促進因素
  • 抑製器
  • 市場機會
  • 挑戰

第 8 章全球心肺旁路配件市場:COVID-19 的影響

第 9 章全球心肺旁路配件市場:按產品

  • 概述
  • 氧氣供給器
    • 按類型
    • 按可用性
  • ECMO 設備
    • 旋轉泵
    • 正排量泵
  • 套管
    • 靜脈插管
    • 動脈插管
  • 系統面板
  • 電子氣體混合器/血氣監測儀
  • 溫度監測器
  • 血液濃縮器
  • 過濾器
  • 配件
    • 顏色編碼集
    • LED 控制檯燈
    • 適配器電纜
    • 電纜支架
    • 高速夾具連接器蓋
    • 泵墊片
    • 顯示屏保護膜
    • 滾子泵架
    • 抽屜模塊
    • 冰容器
    • 導管架
    • 其他
  • 熱交換器/加熱器冷卻系統
  • 傳感器
    • 靜脈傳感器
    • 傳感器模塊
    • 頭部測量支架
    • 連接器
    • 其他
  • 管夾
  • 水庫
  • 心臟病發作控制
  • 氣泡檢測器
  • 電動靜脈封堵器
  • 靜脈線夾

第 10 章全球心肺旁路配件市場:按操作

  • 概述
  • 手冊
  • 電動
  • 電池供電

第 11 章全球心肺旁路配件市場:按應用

  • 概述
  • 心臟手術
    • 冠狀動脈搭橋手術
    • 閥門維修/更換
    • 心律失常手術
    • 動脈瘤修復
    • 經心肌激光血運重建術 (TMLR)
    • 頸動脈內膜切除術
    • 心臟移植
    • 其他
    • 用於心臟手術的人工肺
  • 急性呼吸衰竭的治療
  • 肺癌
  • 移植手術
    • 單肺移植
    • 雙側肺移植 (BLT)
    • 兩次肺移植
    • 心肺移植
  • 其他

第 12 章全球心肺旁路配件市場:按年齡

  • 概述
  • 成人
  • 老人
  • 兒童

第 13 章全球心肺旁路配件市場:按最終用戶

  • 概述
  • 醫院
  • 心臟中心
  • 研究和學術機構
  • 門診手術中心
  • 其他

第 14 章全球心肺旁路配件市場:按分銷渠道

  • 概述
  • 直接出價
  • 第三方分銷商
  • 零售額

第 15 章全球心肺旁路配件市場:按地區

  • 概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 16 章全球心肺旁路配件市場:企業現狀

  • 公司股票分析:世界
  • 公司份額分析:北美
  • 公司股票分析:歐洲
  • 公司股票分析:亞太地區

第17章SWOT分析

第18章公司簡介

  • BOSTON SCIENTIFIC CORPORATION
  • MEDTRONIC
  • ABBOTT
  • EDWARDS LIFESCIENCES CORPORATION
  • ABIOMED
  • GETINGE AB
  • ALUNG TECHNOLOGIES, INC.
  • APC CARDIOVASCULAR LTD
  • BERLIN HEART
  • BRAILE BIOMEDICA
  • EUROSETS
  • JARVIK HEART, INC.
  • LIVANOVA PLC
  • MICROPORT SCIENTIFIC CORPORATION
  • NARANG MEDICAL LIMITED
  • NIPRO
  • SCHNELL MEDICAL CORP.
  • SURGE CARDIOVASCULAR
  • TECHNOWOOD INTERNATIONAL PTE. LTD.
  • TELEFLEX INCORPORATED
  • TERUMO CORPORATION
  • XENIOS AG

第19章 問卷

第20章 相關報告

目錄

Global cardiopulmonary bypass accessory market is projected to register a CAGR of 5.8% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Global Cardiopulmonary Bypass Accessory Equipment Market, By Product (Oxygenator, ECMO Machine, Pumps, Cannula, Temperature Monitors, Heat Exchanger, Filters, Tubing Clamps, Hemoconcentrators, System Panel, Sensor and Accessories, Cardioplegia Control, Reservoir, Bubble Detector, Electronic Gas Blender, Electrical Venous Occluder, Venous Line Clamp and Accessories), Operation (Manually Operated, Electrically Operated and Battery Operated), Application (Cardiac Surgery, Cardiac Surgery Oxygenators, Acute Respiratory Failure Treatment, Lung Cancer, Transplant Operation and Others), Age (Adult, Geriatric and Pediatric), End User (Hospitals, Cardiac Centers, Research and Academic Institutions, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Chile, Columbia, Costa Rica, Cuba, Peru, Uruguay, Bolivia and Rest of South America) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the global cardiopulmonary bypass accessory market are:

  • Strategic initiatives by key players
  • Growing demand of equipment in the market because of high prevalence of cardiovascular diseases
  • Awareness campaign programs related to heart problems

Market Players:

The key market players for global cardiopulmonary bypass accessory equipment market are listed below:

  • Medtronic
  • LivaNova PLC
  • Braile Biomedica
  • MERA
  • Technowood International Pte. Ltd.
  • Narang Medical Limited
  • EUROSETS
  • Teleflex Incorporated
  • Getinge AB
  • Terumo Corporation
  • Surge Cardiovascular
  • Abbott
  • Edwards Lifesciences Corporation
  • SCHNELL MEDICAL CORP.
  • NIPRO
  • XENIOS AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA)
  • Advin Health Care
  • Boston Scientific Corporation
  • APC Cardiovascular Ltd
  • MicroPort Scientific Corporation
  • Alung Technologies, Inc.
  • Berlin Heart
  • Jarvik Heart, Inc.
  • ABIOMED

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: REGIONAL SUMMARY

  • 5.1 NORTH AMERICA
  • 5.2 EUROPE
  • 5.3 ASIA-PACIFIC
  • 5.4 SOUTH AMERICA
  • 5.5 MIDDLE EAST AND AFRICA

6 REGULATORY NETWORK

  • 6.1 UNITED STATES
  • 6.2 EUROPE
  • 6.3 CHINA
  • 6.4 AUSTRALIA

7 MARKET OVERVIEW

  • 7.1 DRIVERS
    • 7.1.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES
    • 7.1.2 GROWING GERIATRIC POPULATION
    • 7.1.3 RISING HEALTHCARE EXPENDITURE
    • 7.1.4 INCREASING NUMBER OF CHRONIC DISEASES
    • 7.1.5 INITIATIVES TAKEN BY MANUFACTURERS
  • 7.2 RESTRAINTS
    • 7.2.1 STRINGENT GOVERNMENT REGULATIONS
    • 7.2.2 HIGH COST OF EQUIPMENT
  • 7.3 OPPORTUNITIES
    • 7.3.1 INCREASING AWARENESS PROGRAM
    • 7.3.2 GROWING MEDICAL TOURISM
    • 7.3.3 RISING DISPOSABLE INCOME
    • 7.3.4 GROWING INFRASTRUCTURE FACILITIES
  • 7.4 CHALLENGES
    • 7.4.1 SHORTAGE OF SKILLED PROFESSIONALS
    • 7.4.2 EMERGENCE OF COVID-19

8 IMPACT OF COVID-19 ON T HE GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET

  • 8.1 IMPACT ON PRICE
  • 8.2 IMPACT ON DEMAND
  • 8.3 IMPACT ON SUPPLY
  • 8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19

8.5 CONCLUSION:

9 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY PRODUCT

  • 9.1 OVERVIEW
  • 9.2 OXYGENATORS
    • 9.2.1 OXYGENATOR BY TYPE
      • 9.2.1.1 MEMBRANE OXYGENATOR
      • 9.2.1.2 FILM OXYGENATOR
      • 9.2.1.3 BUBBLE OXYGENATOR
      • 9.2.1.4 OTHERS
    • 9.2.2 OXYGENATORS BY USABILITY
      • 9.2.2.1 DISPOSABLE
      • 9.2.2.2 REUSABLE
  • 9.3 ECMO MACHINE
  • 9.4 PUMPS
    • 9.4.1 ROTARY PUMPS
      • 9.4.1.1 AXIAL (ARCHIMEDES SCREW)
      • 9.4.1.2 RADIAL (CENTRIFUGAL PUMP)
      • 9.4.1.3 DIAGONAL
    • 9.4.2 DISPLACEMENT PUMPS
      • 9.4.2.1 ROLLER PUMPS
        • 9.4.2.1.1 DOUBLE ROLLER PUMP
        • 9.4.2.1.2 SINGLE ROLLER PUMPS
      • 9.4.2.2 NON INCLUSIVE ROLLER PUMP
  • 9.5 CANNULA
    • 9.5.1 VENOUS CANNULA
      • 9.5.1.1 SINGLE STAGE CANNULA
      • 9.5.1.2 DOUBLE STAGE CANNULA
    • 9.5.2 ARTERIAL CANNULA
  • 9.6 SYSTEM PANEL
  • 9.7 ELECTRONIC GAS BLENDER/BLOOD GAS MONITOR
  • 9.8 TEMPERATURE MONITORS
  • 9.9 HEMOCONCENTRATORS
  • 9.10 FILTERS
  • 9.11 ACCESSORIES
    • 9.11.1 COLOUR CODING SET
    • 9.11.2 LED CONSOLE LAMP
    • 9.11.3 ADOPTER CABLE
    • 9.11.4 CABLE HOLDER
    • 9.11.5 COVER FOR FAST CLAMP CONNECTOR
    • 9.11.6 PUMP SPACER
    • 9.11.7 DISPLAY PROTECTOR
    • 9.11.8 SHELF FOR ROLLER PUMP
    • 9.11.9 DRAWER MODULE
    • 9.11.10 ICE CONTAINER
    • 9.11.11 TUBING GUIDE HOLDER
    • 9.11.12 OTHERS
  • 9.12 HEAT EXCHANGER/HEATER COOLER SYSTEM
  • 9.13 SENSOR
    • 9.13.1 VENOUS SENSOR
    • 9.13.2 SENSOR MODULE
    • 9.13.3 HOLDER FOR MEASURING HEAD
    • 9.13.4 CONNECTORS
    • 9.13.5 OTHERS
  • 9.14 TUBING CLAMPS
  • 9.15 RESERVOIR
  • 9.16 CARDIOPLEGIA CONTROL
  • 9.17 BUBBLE DETECTOR
  • 9.18 ELECTRICAL VENOUS OCCLUDER
  • 9.19 VENOUS LINE CLAMP

10 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY OPERATION

  • 10.1 OVERVIEW
  • 10.2 MANUALLY OPERATED
  • 10.3 ELECTRICALLY OPERATED
  • 10.4 BATTERY OPERATED

11 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY APPLICATION

  • 11.1 OVERVIEW
  • 11.2 CARDIAC SURGERY
    • 11.2.1 CORONARY ARTERY BYPASS SURGERY
    • 11.2.2 VALVE REPAIR OR REPLACEMENT
      • 11.2.2.1 STENOSIS
      • 11.2.2.2 REGUGITATION
    • 11.2.3 ARRHYTHMIA SURGERY
    • 11.2.4 ANEURSYM REPAIR
    • 11.2.5 TRANSMYOCARDIAL LASER REVASCULARIZATION (TMLR)
    • 11.2.6 CAROTID ENDATERECTOMY
    • 11.2.7 HEART TRNASPLANT
    • 11.2.8 OTHERS
    • 11.2.9 CARDIAC SURGERY OXYGENATORS
      • 11.2.9.1 CORONARY ARTERY BYPASS GRAFTING
      • 11.2.9.2 HEART VALVE REPAIR AND REPLACEMENT
      • 11.2.9.3 VENTRICULAR ASSISTED DEVICE (VAD) OR TOTAL ARTIFICIAL HEART (TAF) INSERTION
      • 11.2.9.4 PACEMAKER OF ICD IMPLANTATION
      • 11.2.9.5 HEART TRANSPLANT
      • 11.2.9.6 PERCUTANEOUS CORONARY INTERVENTION
      • 11.2.9.7 CARDIAC CATHETERIZATION
      • 11.2.9.8 INTRA-AORTIC BALLOON PUMP
      • 11.2.9.9 OTHERS
  • 11.3 ACUTE RESPIRATORY FAILURE TREATMENT
    • 11.3.1 ACUTE RESPIRATORY FAILURE TYPE 1
    • 11.3.2 ACUTE RESPIRATORY FAILURE TYPE 2
  • 11.4 LUNG CANCER
  • 11.5 TRANSPLANT OPERATION
    • 11.5.1 SINGLE LUNG TRANSPLANTATION
    • 11.5.2 BILATERAL LUNG TRANSPLANTATION (BLT)
    • 11.5.3 DOUBLE LUNG TRANSPLANTATION
    • 11.5.4 HEART-LUNG TRANSPLANTATION
  • 11.6 OTHERS

12 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY AGE

  • 12.1 OVERVIEW
  • 12.2 ADULT
  • 12.3 GERIATRIC
  • 12.4 PEDIATRIC

13 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 HOSPITALS
  • 13.3 CARDIAC CENTERS
  • 13.4 RESEARCH AND ACADEMIC INSTITUTIONS
  • 13.5 AMBULATORY SURGICAL CENTERS
  • 13.6 OTHERS

14 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 DIRECT TENDER
  • 14.3 THIRD PARTY DISTRIBUTOR
  • 14.4 RETAIL SALES

15 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY REGION

  • 15.1 OVERVIEW
  • 15.2 NORTH AMERICA
    • 15.2.1 U.S.
    • 15.2.2 CANADA
    • 15.2.3 MEXICO
  • 15.3 EUROPE
    • 15.3.1 GERMANY
    • 15.3.2 FRANCE
    • 15.3.3 U.K.
    • 15.3.4 ITALY
    • 15.3.5 NETHERLANDS
    • 15.3.6 SWITZERLAND
    • 15.3.7 SPAIN
    • 15.3.8 RUSSIA
    • 15.3.9 BELGIUM
    • 15.3.10 TURKEY
    • 15.3.11 REST OF EUROPE
  • 15.4 ASIA-PACIFIC
    • 15.4.1 CHINA
    • 15.4.2 JAPAN
    • 15.4.3 AUSTRALIA
    • 15.4.4 SOUTH KOREA
    • 15.4.5 SINGAPORE
    • 15.4.6 INDIA
    • 15.4.7 THAILAND
    • 15.4.8 MALAYSIA
    • 15.4.9 INDONESIA
    • 15.4.10 PHILIPPINES
    • 15.4.11 REST OF ASIA-PACIFIC
  • 15.5 SOUTH AMERICA
    • 15.5.1 BRAZIL
    • 15.5.2 ARGENTINA
    • 15.5.3 CHILE
    • 15.5.4 COLUMBIA
    • 15.5.5 COSTA RICA
    • 15.5.6 CUBA
    • 15.5.7 PERU
    • 15.5.8 URUGUAY
    • 15.5.9 BOLIVIA
    • 15.5.10 REST OF SOUTH AMERICA
  • 15.6 MIDDLE EAST AND AFRICA
    • 15.6.1 SOUTH AFRICA
    • 15.6.2 SAUDI ARABIA
    • 15.6.3 U.A.E.
    • 15.6.4 EGYPT
    • 15.6.5 ISRAEL
    • 15.6.6 REST OF MIDDLE EAST AND AFRICA

16 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 16.3 COMPANY SHARE ANALYSIS: EUROPE
  • 16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 SWOT ANALYSIS

18 COMPANY PROFILE

  • 18.1 BOSTON SCIENTIFIC CORPORATION
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENT
  • 18.2 MEDTRONIC
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENTS
  • 18.3 ABBOTT
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENTS
  • 18.4 EDWARDS LIFESCIENCES CORPORATION
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENTS
  • 18.5 ABIOMED
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 PRODUCT PORTFOLIO
    • 18.5.4 RECENT DEVELOPMENTS
  • 18.6 GETINGE AB
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 REVENUE ANALYSIS
    • 18.6.3 COMPANY SHARE ANALYSIS
    • 18.6.4 PRODUCT PORTFOLIO
    • 18.6.5 RECENT DEVELOPMENT
  • 18.7 ALUNG TECHNOLOGIES, INC.
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 PRODUCT PORTFOLIO
    • 18.7.3 RECENT DEVELOPMENT
  • 18.8 APC CARDIOVASCULAR LTD
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 PRODUCT PORTFOLIO
    • 18.8.3 RECENT DEVELOPMENT
  • 18.9 BERLIN HEART
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 PRODUCT PORTFOLIO
    • 18.9.3 RECENT DEVELOPMENT
  • 18.10 BRAILE BIOMEDICA
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 PRODUCT PORTFOLIO
    • 18.10.3 RECENT DEVELOPMENTS
  • 18.11 EUROSETS
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENTS
  • 18.12 JARVIK HEART, INC.
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 PRODUCT PORTFOLIO
    • 18.12.3 RECENT DEVELOPMENT
  • 18.13 LIVANOVA PLC
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 REVENUE ANALYSIS
    • 18.13.3 PRODUCT PORTFOLIO
    • 18.13.4 RECENT DEVELOPMENTS
  • 18.14 MICROPORT SCIENTIFIC CORPORATION
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 REVENUE ANALYSIS
    • 18.14.3 PRODUCT PORTFOLIO
    • 18.14.4 RECENT DEVELOPMENT
  • 18.15 NARANG MEDICAL LIMITED
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 PRODUCT PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENT
  • 18.16 NIPRO
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 PRODUCT PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENT
  • 18.17 SCHNELL MEDICAL CORP.
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 PRODUCT PORTFOLIO
    • 18.17.3 RECENT DEVELOPMENT
  • 18.18 SURGE CARDIOVASCULAR
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENT
  • 18.19 TECHNOWOOD INTERNATIONAL PTE. LTD.
    • 18.19.1 COMPANY SNAPSHOT
    • 18.19.2 PRODUCT PORTFOLIO
    • 18.19.3 RECENT DEVELOPMENT
  • 18.20 TELEFLEX INCORPORATED
    • 18.20.1 COMPANY SNAPSHOT
    • 18.20.2 REVENUE ANALYSIS
    • 18.20.3 PRODUCT PORTFOLIO
    • 18.20.4 RECENT DEVELOPMENT
  • 18.21 TERUMO CORPORATION
    • 18.21.1 COMPANY SNAPSHOT
    • 18.21.2 REVENUE ANALYSIS
    • 18.21.3 PRODUCT PORTFOLIO
    • 18.21.4 RECENT DEVELOPMENTS
  • 18.22 XENIOS AG (A SUBSIDIARY OF FRESENIUS MEDICAL CARE AG & CO. KGAA)
    • 18.22.1 COMPANY SNAPSHOT
    • 18.22.2 REVENUE ANALYSIS
    • 18.22.3 PRODUCT PORTFOLIO
    • 18.22.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SEGMENTATION 71
  • FIGURE 2 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: DATA TRIANGULATION 74
  • FIGURE 3 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: DROC ANALYSIS 75
  • FIGURE 4 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS 76
  • FIGURE 5 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET : COMPANY RESEARCH ANALYSIS 76
  • FIGURE 6 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS 79
  • FIGURE 7 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: DBMR MARKET POSITION GRID 80
  • FIGURE 8 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID 82
  • FIGURE 9 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: VENDOR SHARE ANALYSIS 83
  • FIGURE 10 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SEGMENTATION 87
  • FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES IS EXPECTED TO DRIVE THE GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 88
  • FIGURE 12 OXYGENATOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET IN 2021 & 2028 88
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 89
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT IN THE FORECAST PERIOD OF 2021 TO 2028 90
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET 100
  • FIGURE 16 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT, 2020 112
  • FIGURE 17 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 113
  • FIGURE 18 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY PRODUCT, CAGR (2019-2028) 114
  • FIGURE 19 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY PRODUCT, LIFELINE CURVE 115
  • FIGURE 20 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY OPERATION, 2020 137
  • FIGURE 21 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY OPERATION, 2019-2028 (USD MILLION) 138
  • FIGURE 22 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY OPERATION, CAGR (2019-2028) 138
  • FIGURE 23 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY OPERATION, LIFELINE CURVE 139
  • FIGURE 24 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY APPLICATION, 2020 144
  • FIGURE 25 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 145
  • FIGURE 26 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY APPLICATION, CAGR (2019-2028) 145
  • FIGURE 27 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY APPLICATION, LIFELINE CURVE 146
  • FIGURE 28 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY AGE, 2020 156
  • FIGURE 29 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY AGE, 2019-2028 (USD MILLION) 157
  • FIGURE 30 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY AGE, CAGR (2019-2028) 157
  • FIGURE 31 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY AGE, LIFELINE CURVE 158
  • FIGURE 32 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY END USER, 2020 162
  • FIGURE 33 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION) 163
  • FIGURE 34 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY END USER, CAGR (2019-2028) 163
  • FIGURE 35 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY END USER, LIFELINE CURVE 164
  • FIGURE 36 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020 169
  • FIGURE 37 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 170
  • FIGURE 38 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, CAGR (2019-2028) 170
  • FIGURE 39 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, LIFELINE CURVE 171
  • FIGURE 40 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 176
  • FIGURE 41 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY REGION (2020) 178
  • FIGURE 42 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY REGION (2021 & 2028) 178
  • FIGURE 43 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY REGION (2020 & 2028) 179
  • FIGURE 44 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 180
  • FIGURE 45 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 183
  • FIGURE 46 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020) 185
  • FIGURE 47 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 185
  • FIGURE 48 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 186
  • FIGURE 49 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 187
  • FIGURE 50 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 221
  • FIGURE 51 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020) 223
  • FIGURE 52 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 223
  • FIGURE 53 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020 & 2028) 224
  • FIGURE 54 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 225
  • FIGURE 55 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 314
  • FIGURE 56 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020) 316
  • FIGURE 57 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 316
  • FIGURE 58 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020 & 2028) 317
  • FIGURE 59 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 318
  • FIGURE 60 SOUTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 409
  • FIGURE 61 SOUTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020) 411
  • FIGURE 62 SOUTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 411
  • FIGURE 63 SOUTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020 & 2028) 412
  • FIGURE 64 SOUTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 413
  • FIGURE 65 MIDDLE EAST AND AFRICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: SNAPSHOT (2020) 496
  • FIGURE 66 MIDDLE EAST AND AFRICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020) 498
  • FIGURE 67 MIDDLE EAST AND AFRICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2021 & 2028) 498
  • FIGURE 68 MIDDLE EAST AND AFRICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY COUNTRY (2020 & 2028) 499
  • FIGURE 69 MIDDLE EAST AND AFRICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: BY PRODUCT (2021-2028) 500
  • FIGURE 70 GLOBAL CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: COMPANY SHARE 2020 (%) 550
  • FIGURE 71 NORTH AMERICA CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: COMPANY SHARE 2020 (%) 551
  • FIGURE 72 EUROPE CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: COMPANY SHARE 2020 (%) 552
  • FIGURE 73 ASIA-PACIFIC CARDIOPULMONARY BYPASS ACCESSORY EQUIPMENT MARKET: COMPANY SHARE 2020 (%) 553